Arthur Krieg to Vaccines, DNA
This is a "connection" page, showing publications Arthur Krieg has written about Vaccines, DNA.
Connection Strength
1.227
-
Krieg AM. Immune effects and mechanisms of action of CpG motifs. Vaccine. 2000 Nov 08; 19(6):618-22.
Score: 0.170
-
Krieg AM, Wagner H. Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA. Immunol Today. 2000 Oct; 21(10):521-6.
Score: 0.168
-
Krieg AM. Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides. Biochim Biophys Acta. 1999 Dec 10; 1489(1):107-16.
Score: 0.159
-
Krieg AM, Yi AK, Schorr J, Davis HL. The role of CpG dinucleotides in DNA vaccines. Trends Microbiol. 1998 Jan; 6(1):23-7.
Score: 0.139
-
Krieg AM. AIMing 2 defend against intracellular pathogens. Nat Immunol. 2010 May; 11(5):367-9.
Score: 0.082
-
Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002; 20:709-60.
Score: 0.045
-
Krieg AM, Davis HL. Enhancing vaccines with immune stimulatory CpG DNA. Curr Opin Mol Ther. 2001 Feb; 3(1):15-24.
Score: 0.043
-
McCluskie MJ, Weeratna RD, Krieg AM, Davis HL. CpG DNA is an effective oral adjuvant to protein antigens in mice. Vaccine. 2000 Nov 22; 19(7-8):950-7.
Score: 0.043
-
Krieg AM. The role of CpG motifs in innate immunity. Curr Opin Immunol. 2000 Feb; 12(1):35-43.
Score: 0.040
-
Krieg AM. CpG oligonucleotides as immune adjuvants. Ernst Schering Res Found Workshop. 2000; (30):105-18.
Score: 0.040
-
Jones TR, Obaldia N, Gramzinski RA, Charoenvit Y, Kolodny N, Kitov S, Davis HL, Krieg AM, Hoffman SL. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. Vaccine. 1999 Aug 06; 17(23-24):3065-71.
Score: 0.039
-
Hartmann G, Krieg AM. CpG DNA and LPS induce distinct patterns of activation in human monocytes. Gene Ther. 1999 May; 6(5):893-903.
Score: 0.038
-
Kovarik J, Bozzotti P, Love-Homan L, Pihlgren M, Davis HL, Lambert PH, Krieg AM, Siegrist CA. CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming. J Immunol. 1999 Feb 01; 162(3):1611-7.
Score: 0.038
-
Krieg AM. CpG DNA: a novel immunomodulator. Trends Microbiol. 1999 Feb; 7(2):64-5.
Score: 0.038
-
Krieg AM. Direct immunologic activities of CpG DNA and implications for gene therapy. J Gene Med. 1999 Jan-Feb; 1(1):56-63.
Score: 0.037
-
Brazolot Millan CL, Weeratna R, Krieg AM, Siegrist CA, Davis HL. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc Natl Acad Sci U S A. 1998 Dec 22; 95(26):15553-8.
Score: 0.037
-
Weeratna R, Brazolot Millan CL, Krieg AM, Davis HL. Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev. 1998 Aug; 8(4):351-6.
Score: 0.036
-
Davis HL, Weeratna R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM, Weeranta R. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol. 1998 Jan 15; 160(2):870-6.
Score: 0.035